Since its inception in 2012, Vazyme has been committed to its mission “Science and Technology Make Life Healthier”; Focus on technological innovation and continuous expansion of the application are. They currently have a portfolio of more than 200 types of genetically modified recombinases, more than 1,000 types of high-performance antigens, monoclonal antibodies and other key raw materials, as well as more than 600 finished products.
As a research and development company, they are committed to the highest standards of ethics, accountability and professionalism. Our global research and development activities enable us to deliver quality products, solutions and services to our customers and, most importantly, to do our utmost to meet unmet customer needs. Today they are present in more than 60 countries and regions around the world, bringing us closer to our local customers.
They believe that good purpose makes good business, and good business makes a better world. Providing reliable products and services is our way of creating a better future for all.
